查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1801251

大肠桿菌检测市场规模、份额、趋势及预测（按产品、检测类型、最终用户和地区），2025 年至 2033 年

E. Coli Testing Market Size, Share, Trends and Forecast by Product, Test Type, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球大肠桿菌检测市场规模达23亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到40亿美元，2025年至2033年的复合年增长率为6.4%。目前，北美占据市场主导地位，2024年的市占率将超过35.8%。该区域市场主要受到严格的监管协议、健全的医疗基础设施以及日益增长的水和食品安全检测需求的影响。

全球大肠桿菌检测市场正在经历扩张，这主要得益于人们对水源性疾病和食源性疾病的认识不断提高，以及水源和食品安全监管框架的日益严格。大肠桿菌疫情的频传，刺激了新兴地区和已开发地区对创新检测方法的需求不断增长。此外，分子诊断技术的创新和自动化检测系统的日益普及也进一步推动了市场的成长。此外，人们对公共卫生和健康的日益重视，尤其是在城市地区，促使人们在先进的检测基础设施上投入巨资，从而扩大了全球范围内大肠桿菌检测解决方案的采用。

美国在全球大肠桿菌检测市场中占有重要份额，主要得益于严格执行的食品安全政策、稳健的医疗基础设施以及公众对食源性疾病认识的不断提高。食品和饮料行业大肠桿菌疫情的频传，大大增强了对可靠检测解决方案的需求。例如，2024 年 11 月，美国着名胡萝卜生产商 Grimmway Farms 因大肠桿菌爆发召回有机小胡萝卜，导緻美国 18 个州出现 39 例。此外，增加对研究计画的投资和快速检测技术的进步也有助于市场扩张。此外，随着包括美国农业部和美国食品药物管理局在内的监管机构强制执行严格的规定，许多企业正在迅速选择尖端诊断工具来应对风险并保障客户安全。这种稳健的监管环境支持着市场的持续成长。

大肠桿菌检测市场趋势：

快速诊断测试的需求不断增长

随着对胃肠道感染（其中最相关的病原体是大肠桿菌）快速诊断的需求日益增长，高速检测方法也应运而生。传统的实验室培养需要两週时间才能鑑定出大肠桿菌，而新型PCR检测方法，例如赛默飞世尔的TaqPath肠道细菌选择性检测试剂盒，可以在大约两小时内得到结果。这种快速的检测速度使医疗服务提供者能够更迅速地诊断和治疗感染，从而减少患者的等待时间和住院时间。例如，根据一篇研究文章，TaqPath试剂盒的敏感度和特异性超过98%，确保结果始终可靠。快速诊断方法的发展趋势对于控制食源性疾病疫情至关重要，因为它能够及时干预，减少感染的传播和影响。它还可以一次检测93个样本，从而提高实验室的通量，即使在高容量的临床环境中也能提高快速诊断的可能性。

日益重视食品安全法规

全球严格的食品安全法规推动了对先进大肠桿菌检测解决方案的需求。监管机构强调遵守检测规程，以降低食品生产和分销链中的污染风险。例如，根据产业报告，大肠桿菌污染每年在美国导致约73,000人患病，其中约2,200人住院，61人死亡。此外，此趋势正在推动自动化检测系统的采用，该系统可提供可靠且可重复的结果，在确保合规性的同时优化营运效率。此外，消费者对食品安全和卫生的意识不断提高，进一步鼓励业界投资于强大的检测框架，以保障公众健康并维护品牌声誉。

扩大即时检验

大肠桿菌的即时检测 (POC) 正日益获得 PCR、LAMP 和质谱等分子诊断技术的支持，这些技术能够快速、现场地检测水、食物和粪便样本中的病原体。 PCR 尤其适用于检测水和粪便样本中的大肠桿菌，为医护人员提供更可靠的方法，以便即时诊断感染并启动治疗。 LAMP DNA 扩增技术还可以一步检测食物、粪便和环境样本中的大肠桿菌，该过程既适用于现场应用，也适用于资源有限的环境。一篇研究文章指出，质谱技术也可用于对细菌和病毒（例如大肠桿菌）进行分型，以详细研究其亚型和感染源。 IMS（免疫磁分离）技术有助于提高从疫情研究所必需的环境水样本中回收 O157:H7 大肠桿菌的效率。其他新兴技术，包括 CRISPR/Cas 平台和基于智慧型手机的数位化方法，提高了大肠桿菌检测的可及性和速度，进一步推动了分子诊断在即时诊断 (POC) 中的应用。这些创新有助于更有效率、更及时地进行诊断，降低医疗成本，并改善患者预后，尤其是在紧急护理和偏远地区。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球大肠桿菌检测市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 耗材
  • 仪器

第七章：市场区隔：依测试类型

  • 环境测试
    • 主要类型
      • 膜过滤（MF）
      • 多管发酵（MTF）
      • 酵素底物法
  • 临床试验
    • 主要类型
      • 聚合酶炼式反应（PCR）检测
      • 酵素连结免疫吸附试验（EIA）
      • 其他的

第八章：市场区隔：按最终用户

  • 医院和诊所
  • 诊断实验室
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章：SWOT分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accugen Laboratories Inc.
    • Alere Inc. (Abbott Laboratories)
    • BD (Becton Dickinson and Company)
    • bioMerieux (INSTITUT MERIEUX)
    • Bio-RAD Laboratories Inc.
    • Enzo Life Sciences Inc. (Enzo Biochem Inc.)
    • Idexx Laboratories Inc.
    • Johnson & Johnson
    • Meridian Bioscience Inc.
    • Nanologix Inc.
    • Pro-Lab Diagnostics
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A2368

The global E. coli testing market size was valued at USD 2.3 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.0 Billion by 2033, exhibiting a CAGR of 6.4% from 2025-2033. North America currently dominates the market, holding a market share of over 35.8% in 2024. This regional market is mainly influenced by strict regulatory protocols, robust healthcare infrastructure, and magnified requirement for water and food safety testing.

The global E. coli testing market is witnessing expansion chiefly due to heightening awareness regarding water and foodborne illnesses, combined with stricter regulatory frameworks for water and food safety. Amplifying incidents of E. coli outbreaks have incentivized accelerated need for innovative testing methods in emerging as well as developed regions. In addition to this, technological innovations in molecular diagnostics and the bolstering utilization of automated testing systems are further fueling market growth. Moreover, the growing emphasis on public sanitation and health, specifically in urban zones, is prompting heavy investments in advanced testing infrastructure, magnifying the adoption of E. coli testing solutions worldwide.

The United States accounts for a crucial share in the global E. coli testing market, majorly propelled by stringent implementation of food safety policies, resilient healthcare infrastructure, and amplifying public awareness associated with foodborne illnesses. The heightening occurrence of E. coli outbreaks in the food and beverage sector has significantly strengthened the requirement for dependable testing solutions. For instance, in November 2024, Grimmway Farms, a prominent U.S.-based carrot producer, recalled organic baby carrots due to E. coli outbreak, resulting in 39 cases across 18 U.S. states. In addition, elevating investments in research projects and advancements in rapid testing technologies further aid in market expansion. Furthermore, with regulatory bodies, encompassing the USDA and FDA enforcing stringent adherence, several businesses are rapidly opting for leading-edge diagnostic tools to address risks and facilitate customer safety. This resilient regulatory landscape supports constant market growth.

E. oli Testing Market Trends:

Growing Demand for Rapid Diagnostic Tests

Increases in the demand for quicker diagnostics in gastrointestinal infections, with the pathogen E. coli among the most relevant, have led towards high-speed testing methodologies. While classical laboratory culture takes two weeks for identification of the organism E. coli, newer PCR-based tests, such as Thermo Fisher's TaqPath Enteric Bacterial Select Panel, yield results within approximately two hours. This rapid turnaround allows health providers to diagnose and treat infections more promptly, which consequently decreases patient wait times and hospital stays. For instance, according to a research article, the TaqPath panel provides sensitivity and specificity of over 98%, ensuring that the results are always dependable. The trending towards fast diagnostic methods has been crucial in controlling foodborne disease outbreaks by being able to intervene in a timely manner to reduce the spread and effect of infections. It also allows for testing 93 samples in one run, which can improve laboratory throughput and increase the possibility of rapid diagnosis even with high-volume clinical settings.

Increasing Focus on Food Safety Regulations

Stringent food safety regulations globally are propelling the demand for advanced E. coli testing solutions. Regulatory bodies are emphasizing compliance with testing protocols to mitigate risks of contamination in food production and distribution chains. For instance, as per industry reports, E. coli contamination causes approximately 73,000 illnesses each year in the U.S., resulting in around 2,200 hospitalizations and 61 fatalities. Moreover, this trend is driving the adoption of automated testing systems that deliver reliable and reproducible results, ensuring compliance while optimizing operational efficiency. In addition, rising consumer awareness regarding food safety and hygiene is further encouraging industries to invest in robust testing frameworks to safeguard public health and maintain brand integrity.

Expansion of Point-of-Care Testing

Point-of-care (POC) testing for E. coli increasingly gains support through molecular diagnostic technologies like PCR, LAMP, and mass spectrometry, which provide rapid, on-site results for pathogens in water, food, and stool samples. PCR, particularly, is requisite for the detection of E. coli from water and stool samples, providing a more reliable method for healthcare providers to diagnose infections and initiate treatment in real time. The LAMP DNA amplification technique can also sense the presence of E. coli in food, stool and environmental samples in one step using a process that could be suited for field applications as well as resource-limited settings. According to a research article, the use of mass spectrometry is also realized in the typing of bacteria and viruses, such as E. coli, to study the subtypes and sources of infection in detail. IMS (immunomagnetic separation) facilitates the increase in the yield of recovery of E. coli O157:H7 from environmental water samples essential for outbreak studies. Other emerging technologies, including CRISPR/Cas platforms and smartphone-based digital methods, improve the accessibility and speed of E. coli detection, further pushing the adoption of molecular diagnostics in POC settings. These innovations contribute to more efficient and timely diagnosis, reducing healthcare costs and improving patient outcomes, particularly in urgent care and remote areas.

E. Coli Testing Industry Segmentation:

Analysis by Product:

  • Consumables
  • Instruments

Consumables leads the market with around 83.7% of market share in 2024. This domination is principally propelled by the elevated frequency of test utilization and the requirement for disposable items to guarantee contamination-free and precise results. This category encompasses media, reagents, and test kits leveraged across variety of testing platforms. The recurring profile of consumables in diagnostics prompts a stable need, specifically in major industries, typically including water quality and food safety testing. Furthermore, with the magnifying cases of E. coli outbreaks, the market is actively witnessing amplified utilization of ready-to-use testing kits that adhere to laboratory workflows. Advancements in consumable design, like automated and pre-packaged systems, further improve both precision and efficacy, positioning them as requisite component for on-site as well as laboratory testing. This segment's expansion is highlighted by the extensive demand for constant testing protocols to cater to the safety and regulatory standards on a global level.

Analysis by Test Type:

  • Environmental Test
    • Membrane Filtration (MF)
    • Multiple Tube Fermentation (MTF)
    • Enzyme Substrate Methods
  • Clinical Test
    • Polymerase Chain Reaction (PCR) Tests
    • Enzyme Immunoassays (EIA)
    • Others

Environmental testing (enzyme substrate methods) leads the market with around 61.8% of market share in 2024. This testing exhibits a critical role in assessing E. coli contamination in soil and water, with enzyme substrate methods emerging as an ideal testing procedure. Such methods utilize enzyme-based reactions to detect E. coli with elevated speed and specificity, facilitating feasible evaluations in crucial purposes, including agricultural safety and municipal water testing. Moreover, the cost-efficiency and user-friendliness of enzyme substrate methods have supported their broad range deployment, especially in regions with stringent environmental policies. Furthermore, the test includes adding a substrate to a sample, which exhibits a measurable fluorescence or color change upon interacting with the enzymes of E. coli. This technique significantly lowers the requirement for sophisticated laboratory infrastructure while sustaining resilience, establishing it as a keystone of environmental testing tactics. Additionally, constant innovations in enzyme-based technologies are poised to further solidify this segment's market share.

Analysis by End User:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

Hospitals and clinics lead the market with around 65.8% of market share in 2024. This dominant end user is mainly impacted by their critical role in diagnosing and managing infections. These facilities handle a high volume of patients presenting symptoms of E. coli-associated illnesses, necessitating prompt and accurate diagnostic services. The prevalence of healthcare-associated infections (HAIs) further bolsters the demand for E. coli testing in clinical settings. Moreover, advanced diagnostic tools and rapid testing technologies are extensively employed in hospitals and clinics to ensure timely treatment, reducing complications and preventing outbreaks. In addition, the growing burden of foodborne diseases globally amplifies the need for reliable testing in healthcare institutions. The segment's leadership is further reinforced by stringent regulatory requirements mandating infection control and reporting, which place hospitals and clinics at the forefront of adopting comprehensive E. coli testing protocols.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 35.8%. This regional market is typically driven by a well-established healthcare infrastructure and resilient regulatory systems. The region's strict food safety frameworks, implemented by agencies like the CDC or FDA, have prompted the utilization of cutting-edge testing solutions across the key sectors, such as healthcare, food, or water. Heightening customer awareness related to foodborne illnesses further magnifies need for robust diagnostics. Moreover, technological innovations, encompassing automated detection systems and rapid testing kits, support the market expansion by providing effective and accurate solutions. In addition, substantial investments in research and development initiatives by leading market players fortify the region's domination on a global level. Furthermore, with accelerating incidences of E. coli outbreaks and a resilient emphasis on preemptive measures to guarantee public health, North America continues to bolster advancement and establish benchmarks for global E. coli testing strategies. For instance, as per industry reports, in the 2024-2025 fiscal year, 139 recalls were recorded in Canada, including those related to E. coli risks.

Key Regional Takeaways:

United States E. Coli Testing Market Analysis

In 2024, United States accounted for the 87.60% of the market share in North America. E. coli infections are an important public health concern in the United States because it causes around 265,000 cases and 100 deaths per year. According to a research article, outbreaks and serious illnesses most often occur by Shiga toxin-producing E. coli, or about 40% of all infections from STEC are due to E. coli O157:H7. It shows the symptoms of infection in cases, including diarrhea, abdominal cramps, nausea, vomiting, and low-grade fever; its complications may be kidney failure or HUS. Young children, the elderly, and others who may be suffering from other illnesses fall within those at a higher risk of complications. E. coli further causes UTIs in up to 80% to 90% cases; this is especially seen among women. Recent outbreaks in the U.S. have included contaminated organic carrots and a severe outbreak linked to McDonald's Quarter Pounders in Mountain West states. Due to that, the demand for good E. coli testing in food safety, healthcare, and water treatment continues to grow.

Europe E. Coli Testing Market Analysis

The E. coli testing market in Europe is growing because of strict food safety regulations and increasing health care issues. According to the European Centre for Disease Prevention and Control, in 2023, the EU had the incidence of third-generation cephalosporin-resistant E. coli bloodstream infections at 10.35 per 100,000 people, which is a problem that is increasing with respect to antimicrobial resistance. The ECDC also reported that E. coli isolates harbouring the blaNDM-5 gene were associated with travel abroad from the EU/EEA to Africa and Asia countries. STEC continues to remain a risk, and a recommendation has been made through ECDC to maintain correct hand hygiene, food preparation, and washing of the vegetables. E. coli continues to be a prominent cause of bacterial infections related to enteritis, urinary tract infections, septicaemia, and neonatal meningitis. The above factors increase the demand for high-tech diagnostic tools. Moreover, the countries driving the most demand and innovation are Germany, France, and the UK. Furthermore, food traceability and sustainability have gained focus, leading to investment in novel testing technologies, hence supporting the growth of this market.

Asia Pacific E. Coli Testing Market Analysis

Asia Pacific E. coli testing market is growing at a higher rate due to increased food production and awareness of food safety. According to China's National Health Commission, rapid urbanization and industrial agriculture increase foodborne illnesses including E. coli infections. India reported more than 500 outbreaks of diarrheal diseases in 2023. Among the patient samples, the most common bacteria isolated were E. coli. This means that the governments and private sectors are focusing more on installing efficient testing systems, especially for food and beverage companies. Multiplex PCR and lateral flow immunoassays are popular emerging technologies. In addition, states like Japan and South Korea are actively introducing the most advanced testing processes for food exports. Furthermore, India is increasingly improving the testing infrastructure for domestic purposes. Asia Pacific is considered to be the key region for E. coli testing market growth due to continuously increasing regulatory pressure.

Latin America E. Coli Testing Market Analysis

Rising food safety concerns and increasing outbreaks of foodborne diseases in Latin America is anticipated to increase the demand for E. coli testing. According to a 2023 industrial report, Brazil is a leading country in Latin America in food production and exports, which fuels the E. coli testing market. The meta-analysis of 4,286 samples found that the general prevalence rate of Shiga toxin-producing E. coli (STEC) in Brazil was 1%, with the highest rate in Mato Grosso at 9%. Hot carcasses had the highest rate of positive samples for STEC at 8%. The Ministry of Health in Brazil has stressed the need for testing in the face of food safety requirements, whether for local consumption or for export. Argentina and Mexico are also investing more in food safety and diagnostics. Furthermore, as awareness of foodborne pathogens increases, the region experiences a shift toward faster, more automated testing solutions. Moreover, harsher regulations and standards instituted by governments also complement demand for advanced testing technologies in the market. Regional cooperation furthers the market growth process, as local manufacturers find partnerships with global players to enhance testing capabilities.

Middle East and Africa E. Coli Testing Market Analysis

The Middle East and Africa E. coli testing market is expected to grow due to increasing health issues and the increasing regulatory demands for food safety. According to the World Health Organization, foodborne diseases, including E. coli infection, are among the most concerning in the region and rise annually. The health ministry of Saudi Arabia in 2020 reported 1,270 cases of foodborne diseases, prompting the government to enforce stronger food safety regulations. Even in South Africa, where home-based producers export agricultural produce around the world, E. coli testing becomes important to reach international standards for food safety. Additionally, there is an expansion of both public and private investments in testing infrastructure within the region. Furthermore, the region's diverse geography as well as infrastructure challenges support widespread adoption of emerging technologies especially portable and rapid test kits.

Competitive Landscape:

The market is highly competitive, with leading players focusing on innovation and strategic partnerships to gain market share. Major companies are actively investing in the development of advanced rapid testing solutions to meet the growing demand for efficient and accurate diagnostics. Furthermore, the market features fierce competition among established as well as emerging firms providing niche solutions. In addition, competitive differentiation is typically bolstered by adherence to regulatory policies, technological innovations, and cost-efficiency. Moreover, several companies are augmenting their geographic reach and improving product lines to address the evolving demands of a broader customer base, further magnifying competition in this dynamic market. For instance, in July 2024, Alden, a biotechnology firm, launched its new food safety and quality testing method Suspended Simultaneous Sandwich Assay. This method can efficiently detect E. coli O157 in beef products.

The report provides a comprehensive analysis of the competitive landscape in the E. coli testing market with detailed profiles of all major companies, including:

  • Accugen Laboratories Inc.
  • Alere Inc. (Abbott Laboratories)
  • BD (Becton Dickinson and Company)
  • bioMerieux (INSTITUT MERIEUX)
  • Bio-RAD Laboratories Inc.
  • Enzo Life Sciences Inc. (Enzo Biochem Inc.)
  • Idexx Laboratories Inc.
  • Johnson & Johnson
  • Meridian Bioscience Inc.
  • Nanologix Inc.
  • Pro-Lab Diagnostics
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What is E. coli testing?
  • 2.How big is the E. coli testing market?
  • 3.What is the expected growth rate of the global E. coli testing market during 2025-2033?
  • 4.What are the key factors driving the global E. coli testing market?
  • 5.What is the leading segment of the global E. coli testing market based on product?
  • 6.What is the leading segment of the global E. coli testing market based on test type?
  • 7.What is the leading segment of the global E. coli testing market based on end user?
  • 8.What are the key regions in the global E. coli testing market?
  • 9.Who are the key players/companies in the global E. coli testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global E. Coli Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Environmental Test
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Membrane Filtration (MF)
      • 7.1.2.2 Multiple Tube Fermentation (MTF)
      • 7.1.2.3 Enzyme Substrate Methods
    • 7.1.3 Market Forecast
  • 7.2 Clinical Test
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Polymerase Chain Reaction (PCR) Tests
      • 7.2.2.2 Enzyme Immunoassays (EIA)
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accugen Laboratories Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alere Inc. (Abbott Laboratories)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 bioMerieux (INSTITUT MERIEUX)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio-RAD Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Life Sciences Inc. (Enzo Biochem Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Idexx Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Meridian Bioscience Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Nanologix Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Pro-Lab Diagnostics
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Qiagen N.V.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: E. Coli Testing Market: Major Drivers and Challenges
  • Figure 2: Global: E. Coli Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: E. Coli Testing Market: Breakup by Product (in %), 2024
  • Figure 4: Global: E. Coli Testing Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: E. Coli Testing Market: Breakup by End User (in %), 2024
  • Figure 6: Global: E. Coli Testing Market: Breakup by Region (in %), 2024
  • Figure 7: Global: E. Coli Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: E. Coli Testing (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: E. Coli Testing (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: E. Coli Testing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: E. Coli Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: E. Coli Testing (Environmental Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: E. Coli Testing (Environmental Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: E. Coli Testing (Clinical Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: E. Coli Testing (Clinical Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: E. Coli Testing (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: E. Coli Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: E. Coli Testing (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: E. Coli Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: E. Coli Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: E. Coli Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia Pacific: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia Pacific: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: E. Coli Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Global: E. Coli Testing Industry: SWOT Analysis
  • Figure 71: Global: E. Coli Testing Industry: Value Chain Analysis
  • Figure 72: Global: E. Coli Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: E. Coli Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: E. Coli Testing Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: E. Coli Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: E. Coli Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: E. Coli Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: E. Coli Testing Market Structure
  • Table 7: Global: E. Coli Testing Market: Key Players